In conclusion, although it would be beneficial to regulate Ripk2 signaling to prevent APOs caused by bacterial infections, further studies using animal models are needed to elucidate whether Ripk2 is involved in F. nucleatum-induced APOs and Ripk2 inhibitors are beneficial to prevent the occurrence of APOs. This evidence concerns the gene RIPK2 and bacterial infectious disease.